(Total Views: 345)
Posted On: 02/27/2019 8:41:25 AM
Post# of 15624
Re: Letitride1027 #14344
it states very clearly what the (potential) ratio is,...
the vote is for a R/S no greater than 1-for-500,...additionally the potential decision will not be made or determined until December 31,2019.
the vote is for allowing for a potential R/S to occur,..not that it will.
",...at any ratio up to 1-for-500, at such time as our Board of Directors shall determine, in its sole discretion, during the Company’s 2019 fiscal year ending December 31, 2019
The Special Meeting of Stockholders (the “Meeting”) of OWC Pharmaceutical Research Corp., a Delaware corporation (the “Company”), will be held at the offices of Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, P.C. at 666 Third Avenue , New York, New York 10017 on April 4, 2019, at 10:00 a.m., local time, for the following purpose. Capitalized terms are defined in the attached proxy statement.
1. To authorize our Board of Directors to effect one reverse stock split of our outstanding Common Stock, $0.00001 par value per share, at any ratio up to 1-for-500, at such time as our Board of Directors shall determine, in its sole discretion, during the Company’s 2019 fiscal year ending December 31, 2019;
the vote is for a R/S no greater than 1-for-500,...additionally the potential decision will not be made or determined until December 31,2019.
the vote is for allowing for a potential R/S to occur,..not that it will.
",...at any ratio up to 1-for-500, at such time as our Board of Directors shall determine, in its sole discretion, during the Company’s 2019 fiscal year ending December 31, 2019
The Special Meeting of Stockholders (the “Meeting”) of OWC Pharmaceutical Research Corp., a Delaware corporation (the “Company”), will be held at the offices of Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, P.C. at 666 Third Avenue , New York, New York 10017 on April 4, 2019, at 10:00 a.m., local time, for the following purpose. Capitalized terms are defined in the attached proxy statement.
1. To authorize our Board of Directors to effect one reverse stock split of our outstanding Common Stock, $0.00001 par value per share, at any ratio up to 1-for-500, at such time as our Board of Directors shall determine, in its sole discretion, during the Company’s 2019 fiscal year ending December 31, 2019;
(0)
(0)
